HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £3 | £3 | £3 | £6 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £2 | £3 | £2 | £5 |
| Revenue | £1 | £1 | £0 | £0 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 44.6% | 18.1% | 27% | 27.5% |
| EBITDA | £0 | £0 | -£0 | -£0 |
| % Margin | 2.2% | 8% | -94.1% | -90.2% |
| Net Income | £0 | £0 | -£0 | -£0 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.25 |
| % Growth | -64% | 127.9% | -72% | – |
| Operating Cash Flow | £0 | £0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | £0 | -£0 | -£0 |